AI Summary & Key Takeaways
AI InsightOn the follow-up after 18 months, the symptoms were found to have regressed and echocardiographic parameters improved (ejection fraction~55%).
📌 3 Key Takeaways
Abstract
Patent ductus arteriosus is a congenital heart disease which can cause chronic volume overload leading to congestive heart failure. A 34-year-old woman with rest dyspnea was found to have patent ductus arteriosus and echocardiogram revealed a markedly dilated left ventricle (8.9 cm) and severely-compromised left ventricle systolic functions (ejection fraction~24%). The patent ductus arteriosus was successfully closed percutaneously with Amplatzer occluder device. The patient was discharged on optimal dosages of ramipril, metoprolol, furosemide, spiranolactone and aspirin. On the follow-up after 18 months, the symptoms were found to have regressed and echocardiographic parameters improved (ejection fraction~55%).
Özet
Konjenital bir kalp hastal¤ olan patent duktus arteriyozus (PDA) kronik volüm yüküne ba¤l olarak konjestif kalp yetersizli¤ine neden olabilmektedir. 34 yaflnda istirahatde nefes darl¤ olan bir kadn hastada PDA ile ekokardiyografik olarak ileri derece dilate solventrikül (8.9 cm) ve bozulmufl sol ventrikül sistolik fonksiyonu saptadk (ejeksiyon fraksiyon~24%). Patent duktus arteriyozus Amplatzer tkayc alet ile baflarl bir flekilde kapatld. Hasta optimum doz ramipril, metoprolol, furosemide, spiranolactone ve aspirin tedavisi ile taburcu edildi. 18 aylk takip sonucunda semptomlarda gerileme ve ekokardiyografik parametrelerde düzelme saptand.